Northern Trust’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Northern Trust’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,248	Closed	-$16K	–	4432
2015 Q2	$16K	Sell	4,248 -836	-16%	-$3.54K	﹤0.01%	4159
2015 Q1	$20K	Hold	5,084	–	–	﹤0.01%	4227
2014 Q4	$70K	Hold	5,084	–	–	﹤0.01%	4048
2014 Q3	$63K	Sell	5,084 -8,849	-64%	-$122K	﹤0.01%	4119
2014 Q2	$254K	Sell	13,933 -3,484	-20%	-$59.6K	﹤0.01%	3786
2014 Q1	$378K	Buy	17,417 +1,233	+8%	+$35.7K	﹤0.01%	3618
2013 Q4	$573K	Buy	16,184 +2,686	+20%	+$90K	﹤0.01%	3491
2013 Q3	$489K	Buy	13,498 +409	+3%	+$18.6K	﹤0.01%	3468
2013 Q2	$592K	Buy	+13,089	New	+$593K	﹤0.01%	3421

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Northern Trust's KBIO Position: Q3 2015 in Review

Northern Trust sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2015, closing a stake of 4,248 shares — an estimated $16K sold.

Northern Trust first reported a position in KBIO in Q2 2013 and held it in 9 quarters. The position peaked at $592K in Q2 2013. 14 funds tracked by Wall St. Rank hold KBIO as of Q3 2015.

Northern Trust reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2015 after selling out during the quarter.
Northern Trust sold 4,248 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2015, an estimated $16K.
Northern Trust first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 9 quarters.
Northern Trust's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $592K in Q2 2013.
14 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2015.

Based on Northern Trust's 13F filing for Q3 2015, filed 12 Nov 2015.